schizophrenia
Conditions
Interventions
betahistine group:betahistine
Sponsors
Beijing Huilongguan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with schizophrenia according to DSM-IV; 2. Aged 18-59 years; 3. Han nationality; 4. Patients or legal guardians were informed of the study and signed informed consent; 5. Patients with first episode without antipsychotic treatment or relapse did not use antipsychotics in recent two months; 6. Patients who are willing to use olanzapine alone according to doctor's advice.
Exclusion criteria
Exclusion criteria: 1. Patients with metabolic syndrome; 2. Comorbidity of other mental disorders; 3. There is a serious or unstable physical disease; 4. There was a history of alcohol or drug abuse in the past 12 months, and a history of dependence in the past 6 months; 5. Have a serious history of drug allergy or susceptible individuals; 6. Contraindications of betahistine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MCCB; | — |
Secondary
| Measure | Time frame |
|---|---|
| rbans;weight;PANSS;routine blood test;Blood biochemistry;CGI;UKU; | — |
Countries
China
Contacts
Public ContactWang Yongqian
Beijing Huilongguan Hospital
Outcome results
None listed